We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies.
More information
Accept
Home
About us
NEURAXPHARM
HISTORY HIGHLIGHTS
EXECUTIVE COMMITTEE
OUR COMMITMENT
COMMITMENT TO CNS COMMUNITY
NEURAXPHARM FOUNDATION
CODE OF ETHICS
WHISTLEBLOWING CHANNEL
CNS SPECIALIST
CNS FOCUS
THERAPEUTIC AREAS
CNS R&D STRATEGY
Products
OUR PORTFOLIO
CNS VALUE ADDED MEDICINES
CNS STANDARD GENERICS
CNS CONSUMER HEALTHCARE
Other Services
FDFs – LESVI
GENERIC DOSSIERS
APIs – INKE
DEVELOPMENT & MANUFACTURING
REGULATORY SUPPORT
JOIN US
CONTACT US
NEWSROOM
Neuraxpharm group
See Neuraxpharm’s sites
Austria
Czechia
France
Germany
Hungary
Ireland
Italy
Poland
Portugal
Slovakia
Spain
United Kingdom
Manufacturing plants
FDFs | LESVI
APIs | INKE
YOUR
CNS
SPECIALIST
NEURAXPHARM,
a European leader in pharmaceutical products for the
CENTRAL NERVOUS SYSTEM
SPECIALISED IN THE TREATMENT OF
CENTRAL NERVOUS SYSTEM (CNS) DISORDERS
SINCE 1985
More
THE EUROPEAN CNS PLATFORM
Neuraxpharm has direct presence with its own organisations in the main European markets
Plans of further geographic expansion in Europe
CNS
Focus
We offer a wide range of proven, differentiated and affordable CNS treatment options to patients, healthcare professionals and industry partners
More
We offer a complete spectrum of therapeutic options in
EPILEPSY
PARKINSON'S
PSYCHOSIS / SCHIZOPHRENIA
DEPRESSION
ALZHEIMER'S
as well as a growing portfolio in other CNS indications
More
480M€
TURNOVER
>130
CNS MOLECULES
>80%
EUROPEAN CNS MARKET REACHED WITH OWN PRESENCE
~850
GROUP EMPLOYEES
OUR COMMITMENT
TO THE CNS
COMMUNITY
Know more